AI MARKET SCANNING

Agenus Inc.

📅 Next Catalyst: Nov 05, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +0.02%
MAX GAP RECORD +10.53%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $AGEN
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 05, 2026 Earnings Release 2026-11-05 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 07, 2026 Earnings Release 2026-08-07 (AFTER CLOSE)
-1.87%
May 11, 2026 Earnings Release 2026-05-11 (AFTER CLOSE)
-0.31%
Mar 16, 2026 Earnings Release 2026-03-16 (AFTER CLOSE)
+1.52%
Nov 10, 2025 Earnings Release 2025-11-10 (AFTER CLOSE)
-0.71%
Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE)
+0.00%
May 12, 2025 Earnings Release 2025-05-12 (AFTER CLOSE)
+1.14%
Mar 17, 2025 Earnings Release 2025-03-17 (AFTER CLOSE)
-2.81%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.7%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $AGEN

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-08-06 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1106m +5.26%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗